ada.enesco, Author at European Medical Journal - Page 47 of 66

Dual Brain Stimulation Therapy for Major Depression

Dual brain stimulation therapies significantly outperformed standalone treatments in reducing depression severity, offering new hope for patients with major depressive disorder.

Immune Landscape of Multiple Myeloma Uncovered

A new study provides an in-depth immune atlas of Multiple Myeloma, uncovering dynamic changes in the tumour microenvironment….

Global Diabetes Cases Surpass 800 Million, Highlighting Treatment Inequality

New research shows that diabetes rates have doubled to 800 million adults, but over half remain untreated.

B-Cell Depletion Reduces IgG4 Disease Flare Risk

The trial included 135 adults, randomly assigned to receive either inebilizumab or a placebo for a 52-week treatment period.

Machine Learning Models Predict Success in Stopping Renal Replacement Therapy

Machine learning identifies key factors and predicts success in renal replacement therapy discontinuation for critically ill patients with acute kidney injury.

Rising Trends in Germline Genetic Testing for Prostate Cancer

Recent data shows a significant increase in germline genetic testing for prostate cancer, with a notable rise in urologist involvement.

Which Treatment for Malignant Pleural Effusions Works Best?

No difference in mortality found between indwelling pleural catheters and chemical pleurodesis for treating malignant pleural effusions.

New Study Evaluates VR/AR Headset Accuracy in Diagnosing Diverticulitis

VR/AR headsets could one day match desktops in diagnostic effectiveness, according to a recent study.

Meta-Analysis Reveals Impact of Hypotension on TBI Mortality

Patients with traumatic brain injury (TBI) and hypotension face doubled mortality odds, highlighting the need for precise blood pressure management in clinical practice.

Does Retreating Multiple Myeloma with Previously Refractory Drugs Work?

Patients with late line relapsed/refractory multiple myeloma (RRMM) could benefit from repeat treatment with drugs their disease has previously been refractory to.